The disease progression is invariably accompanied by decreased insulin production and/insulin resistance, altered lipid metabolism, dyslipidemia, which can lead to atherogenesis and elevated risk of atherosclerotic cardiovascular disease (ASCVD) [5]. This evidence concerns the gene INS and Insulin resistance.